Latest Contribution
Aesthetic restoration following GLP-1 agonist–induced facial volume loss
GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®, Rybelsus®) have significantly improved the management of obesity and type 2 diabetes, providing effective weight loss and cardiometabolic benefits. However, as their use becomes more widespread, there has been an increase in...
PhilArt next for 35-year-old knee scar
In our dynamic field, staying ahead means embracing innovation, and understanding the evolving preferences of both practitioners and patients; recognising the trends that shape our industry. The biostimulator injections’ market has rapidly risen to prominence, ranking among the top three...
